Alrgn Bio
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Angel
LATEST DEAL TYPE
$946K
LATEST DEAL AMOUNT
1
INVESTORS
Description
Operator and owner of a food bioprocessing company providing hypoallergenic peanuts. The company combines its patented food grade enzymatic process with current food industry processing equipment to inactivate peanut allergens.
Primary Industry
Biotechnology
Primary Office
- 2901 E Gate City Boulevard
- Suite 2400
- Greensboro, NC 27401
- United States
+1 (919) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Alrgn Bio’s full profile, request a free trial.
Alrgn Bio Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 16-Dec-2016 | $946K | 00000 | Completed | Startup |
Alrgn Bio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Aubrey Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
Alrgn Bio Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Kit McQuiston | Chief Executive Officer, Promoter & Board Member |
3 Former Executives
You’re viewing 1 of 4 executives. Get the full list »Alrgn Bio Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Kit McQuiston | Alrgn Bio | Chief Executive Officer, Promoter & Board Member | 000 0000 |